Of the two human herpesvirus 6 (HHV-6) species, human herpesvirus 6B (HHV-6B)
encephalitis is an important cause of morbidity and mortality after allogeneic hematopoietic …

In spite of an increasing array of investigations, the relationships between viral infections
and allogeneic hematopoietic stem cell transplantation (HSCT) are still controversial, and …

It remains difficult to treat the multiplicity of distinct viral infections that afflict
immunocompromised patients. Adoptive transfer of virus-specific T cells (VSTs) can be safe …

Background. Systemic reactivations of herpesviruses may occur in intensive care unit (ICU)
patients, even in those without prior immune deficiency. However, the clinical relevance of …

Human herpesvirus 6 (HHV-6) reactivation has been associated with acute graft-versus-host-
disease (aGVHD), cytomegalovirus reactivation, and mortality after allogeneic hematopoietic …

Busulfan (Bu) is used as a myeloablative agent in conditioning regimens before allogeneic
hematopoietic cell transplantation (allo-HCT). In line with strategies explored in adults …

This study investigated the impact of human herpesvirus type 6 (HHV6) reactivation within
100 days of allogeneic stem cell transplantation (allo-SCT) on patient outcomes. HHV6 …

Reactivation of human herpesvirus-6 (HHV-6) frequently occurs following hematopoietic
SCT (HSCT), and has been associated with clinical consequences in many patient …

The use of post-transplantation cyclophosphamide (PTCy) for graft-versus-host disease
(GVHD) prophylaxis in recipients of haploidentical and fully matched transplantations is on …

Graft-versus-host disease (GVHD) is an important cause of morbidity and mortality after
allogeneic hematopoietic cell transplantation (HCT). Many studies have suggested that …